• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测口腔鳞状细胞癌术后放疗管理的列线图开发和验证。

Prediction nomogram development and validation for postoperative radiotherapy in the management of oral squamous cell carcinoma.

机构信息

Department of Oral and Maxillofacial Surgery, Royal Brisbane and Women's Hospital, Bowen Bridge Road & Butterfield Street, Herston, Queensland, Australia.

Faculty of Medicine, University of Queensland, Level 2, Mayne Medical Building, 288 Herston Road, Herston, Queensland, Australia.

出版信息

Head Neck. 2023 Jun;45(6):1503-1510. doi: 10.1002/hed.27363. Epub 2023 Apr 5.

DOI:10.1002/hed.27363
PMID:37019874
Abstract

BACKGROUND

Predictive nomograms are useful tools to guide clinicians in estimating disease course. Oral squamous cell carcinoma (OSCC) patients would benefit from an interactive prediction calculator that defines their levels of survival-risk specific to their tumors to guide the use of postoperative radiotherapy (PORT).

METHODS

Patients with OSCC surgically treated with curative intent at four Head and Neck Cancer Centres were recruited retrospectively for development and validation of nomograms. Predictor variables include PORT, age, T and N classification, surgical margins, perineural invasion, and lymphovascular invasion. Outcomes were disease-free, disease-specific, and overall survivals over 5 years.

RESULTS

1296 patients with OSCC were in training cohort for nomogram analysis. Algorithms were developed to show relative benefit of PORT in survivals for higher-risk patients. External validation on 1212 patients found the nomogram to be robust with favorable discrimination and calibration.

CONCLUSION

The proposed calculator can assist clinicians and patients in the decision-making process for PORT.

摘要

背景

预测列线图是一种有用的工具,可以帮助临床医生估计疾病的进程。口腔鳞状细胞癌(OSCC)患者将受益于一个交互式预测计算器,该计算器可以根据肿瘤为他们定义特定的生存风险水平,以指导术后放疗(PORT)的使用。

方法

在四个头颈癌中心接受根治性手术治疗的 OSCC 患者被回顾性招募,用于列线图的开发和验证。预测变量包括 PORT、年龄、T 和 N 分类、手术切缘、神经周围侵犯和血管侵犯。结果是 5 年内无病、疾病特异性和总体生存率。

结果

1296 例 OSCC 患者纳入列线图分析的训练队列。制定了算法来显示 PORT 在高风险患者生存中的相对获益。对 1212 例患者的外部验证发现,该列线图具有良好的判别力和校准度,非常稳健。

结论

所提出的计算器可以帮助临床医生和患者在 PORT 的决策过程中做出决策。

相似文献

1
Prediction nomogram development and validation for postoperative radiotherapy in the management of oral squamous cell carcinoma.预测口腔鳞状细胞癌术后放疗管理的列线图开发和验证。
Head Neck. 2023 Jun;45(6):1503-1510. doi: 10.1002/hed.27363. Epub 2023 Apr 5.
2
Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.列线图预测头颈部鳞状细胞癌术后延迟开始放疗的建立和验证。
JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):455-464. doi: 10.1001/jamaoto.2020.0222.
3
Predicting oral cancer survival-Development and validation of an Asia-Pacific nomogram.预测口腔癌生存情况——亚太列线图的建立与验证。
J Oral Pathol Med. 2023 Aug;52(7):628-636. doi: 10.1111/jop.13454. Epub 2023 May 29.
4
Development and validation of a nomogram for the prediction of lymph node metastasis within 2-year postoperatively in cT1-T2N0 oral squamous cell carcinoma.cT1-T2N0期口腔鳞状细胞癌术后2年内淋巴结转移预测列线图的开发与验证
Head Neck. 2023 Jan;45(1):103-114. doi: 10.1002/hed.27215. Epub 2022 Oct 13.
5
Nomogram prediction for survival of patients with oral cavity squamous cell carcinoma.口腔鳞状细胞癌患者生存的列线图预测
Head Neck. 2016 Dec;38(12):1826-1831. doi: 10.1002/hed.24507. Epub 2016 May 26.
6
Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity Carcinoma.基于淋巴结比率的列线图改善口腔癌特异性风险分层:在指导口腔癌术后管理决策中的潜在作用
JCO Precis Oncol. 2023 Jan;7:e2200365. doi: 10.1200/PO.22.00365.
7
Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2,N0-1): A review.早期口腔癌(pT1-2,N0-1)术后放疗(PORT):综述。
Crit Rev Oncol Hematol. 2019 Nov;143:67-75. doi: 10.1016/j.critrevonc.2019.08.003. Epub 2019 Aug 31.
8
The role of adjuvant radiotherapy in locally advanced T4 mandible squamous cell carcinoma in the N0 patient: a single centre experience.局部晚期 T4 期下颌骨鳞状细胞癌 N0 患者辅助放疗的作用:单中心经验。
Int J Oral Maxillofac Surg. 2022 Oct;51(10):1251-1256. doi: 10.1016/j.ijom.2022.01.003. Epub 2022 Jan 26.
9
An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy.口腔癌列线图预测辅助放疗获益。
JAMA Otolaryngol Head Neck Surg. 2013 Jun;139(6):554-9. doi: 10.1001/jamaoto.2013.3001.
10
The utility of postoperative radiotherapy in intermediate-risk oral squamous cell carcinoma.中危口腔鳞状细胞癌术后放疗的效用。
Int J Oral Maxillofac Surg. 2021 Feb;50(2):143-150. doi: 10.1016/j.ijom.2020.06.006. Epub 2020 Jun 29.

引用本文的文献

1
Development of a Prognostic Nomogram Incorporating the Naples Prognostic Score for Postoperative Oral Squamous Cell Carcinoma Patients.纳入那不勒斯预后评分的术后口腔鳞状细胞癌患者预后列线图的开发。
J Inflamm Res. 2025 Jan 7;18:325-345. doi: 10.2147/JIR.S500518. eCollection 2025.
2
Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery.唇鳞状细胞癌患者术后预后因素的多变量分析
World J Surg Oncol. 2024 Jan 26;22(1):35. doi: 10.1186/s12957-024-03313-9.